What are the differential diagnoses for a painful unilateral vesicular rash consistent with herpes zoster?

Differential Diagnosis for Herpes Zoster

The differential diagnosis for a painful unilateral vesicular rash consistent with herpes zoster primarily includes herpes simplex virus (HSV) infection, contact dermatitis, bacterial skin infections with secondary bacterial or fungal superinfection, and in immunocompromised patients, disseminated fungal infections such as Aspergillus or Fusarium species.

Key Distinguishing Features

Herpes Simplex Virus (HSV)

The most critical differential to distinguish from herpes zoster is HSV infection 1, 2. While both present with vesicular lesions:

• HSV typically causes chronic, poorly healing ulcers in immunocompromised hosts, with ulcerative lesions that rarely include a vesicular component, making clinical diagnosis more difficult 1
• HSV lesions are usually not dermatomally distributed and lack the strict unilateral pattern of herpes zoster
• HSV can present with bilateral involvement, especially in atopic or immunocompromised patients 3, 4
• Tzanck smear cannot differentiate between VZV and HSV—PCR testing is essential for definitive diagnosis 5, 6

Varicella (Primary VZV Infection)

In immunocompromised patients, disseminated herpes zoster can mimic atypical varicella 2:

• Disseminated VZV characteristically begins on face and trunk, then evolves peripherally
• Shows lesions simultaneously in varied stages of infection progression (unlike smallpox) 1
• Lacks the strict dermatomal distribution of localized herpes zoster

Fungal Infections (Immunocompromised Patients)

In patients with cellular immune deficiency, cutaneous mold infections must be considered 2:

• Aspergillus, Mucormycosis, Scedosporium, and Fusarium species can present as papules, nodules, or ulcers
• May have the dermatological appearance of ecthyma gangrenosum
• Skin biopsy is essential for diagnostic purposes in these cases 2
• These infections can occur as manifestations of disseminated disease or primary cutaneous inoculation

Atypical Presentations to Consider

Herpes zoster without vesicles is uncommon but documented 7, 8:

• May present as linear erythematous plaques or purpuric lesions
• Pain in dermatomal distribution may be the only initial clue
• Can be mistaken for leukocytoclastic vasculitis or other dermatoses 7

Genital herpes zoster is rare and frequently misdiagnosed 5, 6:

• VZV found in nearly 3% of virus-positive genital specimens
• Often mistaken for genital HSV infection
• Requires PCR testing to differentiate from zosteriform HSV infection 5

Clinical Algorithm for Differentiation

Step 1: Assess Distribution Pattern

• Strict unilateral dermatomal distribution → strongly suggests herpes zoster 2
• Bilateral or non-dermatomal → consider HSV, disseminated VZV, or other etiologies
• Does not cross midline → characteristic of herpes zoster 9

Step 2: Evaluate Lesion Morphology and Evolution

• Erythematous macules → papules → vesicles → pustules → ulcers in sequence over 24-72 hours → herpes zoster 1, 2
• Vesicles coalesce and form bullae before scabbing → typical herpes zoster 2
• Chronic poorly healing ulcers without vesicular component → consider HSV in immunocompromised 1

Step 3: Consider Host Immune Status

In immunocompromised patients (transplant recipients, chemotherapy, HIV, cellular immune deficiency):

• Lesions may continue developing over 7-14 days (vs. 4-6 days in healthy hosts) 2
• Higher risk of dissemination (10-20% without prompt antiviral therapy) 2
• Must consider fungal infections (Aspergillus, Fusarium) presenting as nodules or ulcers 2
• Secondary bacterial and fungal superinfections complicate chronic ulcerations 2

Step 4: Confirm with Laboratory Testing

• PCR of vesicular fluid is the gold standard for confirming VZV and differentiating from HSV 5, 6
• Tzanck smear shows multinucleated giant cells but cannot distinguish VZV from HSV 5
• Skin biopsy when fungal infection suspected in immunocompromised patients 2

Critical Pitfalls to Avoid

1. Anchoring on unifying diagnosis: When findings are discordant, resist diagnostic simplification—coexisting conditions can occur (e.g., VZV-induced vasculitis) 7

2. Delaying empiric antiviral therapy: When herpes zoster is suspected clinically, initiate treatment immediately without waiting for confirmatory testing, especially in immunocompromised patients 2, 7

3. Assuming vesicles must be present: Herpes zoster can present without typical vesicular eruptions, with only pain in dermatomal distribution 7, 8

4. Missing genital herpes zoster: VZV should be considered in differential diagnosis of genital herpetic lesions, not just HSV 5, 6

5. Overlooking antiviral resistance: In patients already taking prophylactic antivirals (acyclovir, valacyclovir) who develop suspicious lesions, investigate antiviral resistance 2

6. Failing to consider HIV: Herpes zoster, particularly in unusual locations like genital area, may be the first clinical evidence of HIV infection—HIV testing should be performed 5